Close

Syndecan-1

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Neuronal protein that plays several roles in synaptic activity such as regulation of synaptic vesicle trafficking and subsequent neurotransmitter release. Participates as a monomer in synaptic vesicle exocytosis by enhancing vesicle priming, fusion and dilation of exocytotic fusion pores. Mechanistically, acts by increasing local Ca2+ release from microdomains which is essential for the enhancement of ATP-induced exocytosis. Acts also as a molecular chaperone in its multimeric membrane-bound state, assisting in the folding of synaptic fusion components called SNAREs (Soluble NSF Attachment Protein REceptors) at presynaptic plasma membrane in conjunction with cysteine string protein-alpha/DNAJC5. This chaperone activity is important to sustain normal SNARE-complex assembly during aging. Plays also a role in the regulation of the dopamine neurotransmission by associating with the dopamine transporter (DAT1) and thereby modulating its activity.
  • Protein

Loading...
    CAT Product Name Organism Inquiry & Datasheet
    CARD-LX145 Biotinylated Human Syndecan-1 CAR Detection Reagent, His,Avitag™   Add to Cart   Datasheet
    Unable to find the desired product? Explore the Filter Options at the top of the list.
    Key Updates
    Newsletter NEWSLETTER

    The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

    LEARN MORE NEWSLETTER
    New Solution NEW SOLUTION

    CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

    LEARN MORE SOLUTION
    NOVEL SOLUTION NOVEL TECHNOLOGY

    Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

    LEARN MORE NOVEL TECHNOLOGY
    NEW TECHNOLOGY NEW SOLUTION

    Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

    LEARN MORE SOLUTION
    Receive our latest news and insights.